Guess which ASX 200 stock was just downgraded by a leading broker

But don't go hitting the sell button just yet.

| More on:
Three guys in shirts and ties give the thumbs down.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Nufarm Ltd (ASX: NUF) shares have been in great form in recent months.

For example, the ASX 200 stock has risen almost 35% since the start of October.

This leaves the agricultural chemicals company's shares trading within sight of a 52-week high.

Unfortunately, one leading broker is now calling time on its rally and has downgraded its shares.

ASX 200 stock downgraded

According to a note out of Bell Potter, its analysts have downgraded the company's shares to a hold rating with an unchanged price target of $6.35.

While this still implies potential upside of 9% for investors over the next 12 months, the broker feels there isn't a sufficient risk/reward on offer to support a buy rating.

Though, it certainly doesn't think that investors should be offloading the ASX 200 stock right now. It feels it would be well worth holding tight to them given its belief that FY 2025 could be a standout year for the company.

For example, Bell Potter expects Nufarm to report a 4% decline in net profit after tax to $117.6 million in FY 2024. But in FY 2025, it forecasts an impressive 32% jump in profits to $155.7 million and then another 25% increase to $195.6 million in FY 2026.

A key driver of this growth is expected to be the Beyond Yield platform from its Seed Technologies business, Nuseed. The broker commented:

NUF continues to trade at a reasonably large discount to global peers (which in the recent months have re-rated) and we continue to see FY25e as likely to be the year when the Beyond Yield platform takes over as the growth engine for NUF. However, considering the recent share price we move we moderate our rating from Buy to Hold.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Hands reaching high for a trophy with a sunset in the background.
Broker Notes

IAG shares hit multi-year high amid broker prediction of double-digit profit growth

Morgan Stanley has issued a new note on the ASX insurance sector.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

This ASX All Ords stock could rise 25% and pay a 5% yield

Bell Potter has good things to say about this stock. Let's see why it is bullish.

Read more »

Happy man working on his laptop.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Broker Notes

These ASX 200 shares could rise 20% to 65%

Analysts are tipping these shares to deliver big returns in 2025.

Read more »

a group of people stand examining a large glowing cystral ball held in the hands of one of the group members while the others regard it with various expressions of wonder, curiousity and scepticism.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Shot of a young scientist looking stressed while conducting medical research in a laboratory.
Broker Notes

Why this top fundie has a 'loss of confidence' in CSL shares

CSL has a lot of broker support right now but Firetrail has an opposing view on the ASX 200 healthcare…

Read more »